Literature DB >> 28417678

Changes in peripheral blood T-cell balance after percutaneous tumor ablation.

Haruyuki Takaki1, Naoko Imai2, Contessa T Thomas3, Koichiro Yamakado1, Hooman Yarmohammadi3, Etay Ziv3, Govindarajan Srimathveeravalli3, Constantinos T Sofocleous3, Stephen B Solomon3, Joseph P Erinjeri3.   

Abstract

PURPOSE: To evaluate the changes in T-cell balance in peripheral blood following percutaneous tumor ablation.
MATERIAL AND METHODS: Patients underwent thermal ablation including radiofrequency (n = 9) and microwave ablation (n = 5), or cryoablation (n = 5). Target tumors were located in the lung (n = 7), soft tissue (n = 5), liver (n = 4), and bone (n = 3). Patient peripheral blood samples were collected before and within 14 days after ablation. Peripheral blood populations of cytotoxic T-cells (CTL), type-1 (Th1) and type-2 helper T-cells (Th2), and regulatory T-cells (Treg) were measured using flow cytometry. Changes in CTL/Treg and Th1/Th2 ratios before and after ablation therapy were compared using paired t-tests.
RESULTS: Peripheral blood CTL population (27.5 ± 2.1% to 30.2 ± 2.5%, p < .03) and CTL/Treg ratios (18.8 ± 3.7% to 21.6 ± 3.6%, p < .05) increased significantly after ablation. Although a significant increase in CTL/Treg ratios was found after heat-based ablation (18.0 ± 4.4% to 21.6 ± 4.7%, p < .02), it remained unchanged after cryoablation (21.0 ± 7.0% to 21.5 ± 4.3%, p = .92). Th1/Th2 ratio (13.7 ± 3.0% to 17.2 ± 3.5%, p = .12) remained unchanged after ablation.
CONCLUSION: Ablation therapy alters the T-cell balance by increasing the systemic CTL/Treg, ratio. Heat-based ablation might be a more effective approach than cryoablation to enhance systemic anti-tumor immunity.

Entities:  

Keywords:  Radiofrequency ablation; T-cell; cryoablation; lymphocyte; microwave ablation

Mesh:

Year:  2017        PMID: 28417678      PMCID: PMC9382907          DOI: 10.1080/13645706.2017.1310737

Source DB:  PubMed          Journal:  Minim Invasive Ther Allied Technol        ISSN: 1364-5706


  27 in total

1.  Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.

Authors:  Xiaodong Wang; Constantinos T Sofocleous; Joseph P Erinjeri; Elena N Petre; Mithat Gonen; Kinh G Do; Karen T Brown; Anne M Covey; Lynn A Brody; William Alago; Raymond H Thornton; Nancy E Kemeny; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2012-04-26       Impact factor: 2.740

Review 2.  Regulatory T cells in cancer immunotherapy.

Authors:  Hiroyoshi Nishikawa; Shimon Sakaguchi
Journal:  Curr Opin Immunol       Date:  2014-01-14       Impact factor: 7.486

3.  Organ-specific cytokine polarization induced by adoptive transfer of transgenic T cells.

Authors:  Lei Zhang; Elaine F Lizzio; Elena Gubina; Trina Chen; Howard Mostowski; Steven Kozlowski
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

4.  Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.

Authors:  Caroline Erös de Bethlenfalva-Hora; Joachim C Mertens; Anne-Christine Piguet; Joachim Kettenbach; Johannes Schmitt; Luigi Terracciano; Rosemarie Weimann; Jean-François Dufour; Andreas Geier
Journal:  Clin Sci (Lond)       Date:  2014-02       Impact factor: 6.124

5.  Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer.

Authors:  Hiroyuki Suzuki; Nobuhito Chikazawa; Takehiko Tasaka; Junji Wada; Akio Yamasaki; Yoshiki Kitaura; Masae Sozaki; Masao Tanaka; Hideya Onishi; Takashi Morisaki; Mitsuo Katano
Journal:  Cancer Immunol Immunother       Date:  2009-11-12       Impact factor: 6.968

6.  In situ tumor ablation creates an antigen source for the generation of antitumor immunity.

Authors:  Martijn H M G M den Brok; Roger P M Sutmuller; Robbert van der Voort; Erik J Bennink; Carl G Figdor; Theo J M Ruers; Gosse J Adema
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

7.  Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension.

Authors:  Heddwen L Brooks; Meredith Hay; Dennis P Pollow; Jennifer Uhrlaub; Melissa Romero-Aleshire; Kathryn Sandberg; Janko Nikolich-Zugich
Journal:  Hypertension       Date:  2014-06-02       Impact factor: 10.190

Review 8.  Dual roles of immune cells and their factors in cancer development and progression.

Authors:  Brian F Zamarron; WanJun Chen
Journal:  Int J Biol Sci       Date:  2011-05-21       Impact factor: 6.580

9.  Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.

Authors:  M H M G M den Brok; R P M Sutmuller; S Nierkens; E J Bennink; C Frielink; L W J Toonen; O C Boerman; C G Figdor; T J M Ruers; G J Adema
Journal:  Br J Cancer       Date:  2006-09-05       Impact factor: 7.640

10.  Natural and induced T regulatory cells in cancer.

Authors:  Dennis O Adeegbe; Hiroyoshi Nishikawa
Journal:  Front Immunol       Date:  2013-07-11       Impact factor: 7.561

View more
  10 in total

Review 1.  Combined locoregional-immunotherapy for liver cancer.

Authors:  Tim F Greten; Michal Mauda-Havakuk; Bernd Heinrich; Firouzeh Korangy; Bradford J Wood
Journal:  J Hepatol       Date:  2019-02-07       Impact factor: 25.083

Review 2.  Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.

Authors:  Joseph P Erinjeri; Gabriel C Fine; Gosse J Adema; Muneeb Ahmed; Julius Chapiro; Martijn den Brok; Rafael Duran; Stephen J Hunt; D Thor Johnson; Jens Ricke; Daniel Y Sze; Beau Bosko Toskich; Bradford J Wood; David Woodrum; S Nahum Goldberg
Journal:  Radiology       Date:  2019-04-23       Impact factor: 11.105

3.  Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis.

Authors:  Zhou Tian; Baojian Hong; Jianzhong Chen; Zhe Tang
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

4.  Transarterial Embolization Modulates the Immune Response within Target and Nontarget Hepatocellular Carcinomas in a Rat Model.

Authors:  David J Tischfield; Alexey Gurevich; Omar Johnson; Isabela Gatmaytan; Gregory J Nadolski; Michael C Soulen; David E Kaplan; Emma Furth; Stephen J Hunt; Terence P F Gade
Journal:  Radiology       Date:  2022-01-11       Impact factor: 29.146

Review 5.  Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy.

Authors:  Florentine E F Timmer; Bart Geboers; Sanne Nieuwenhuizen; Evelien A C Schouten; Madelon Dijkstra; Jan J J de Vries; M Petrousjka van den Tol; Tanja D de Gruijl; Hester J Scheffer; Martijn R Meijerink
Journal:  Curr Oncol Rep       Date:  2021-04-17       Impact factor: 5.075

Review 6.  [Current Status and Progress of Thermal Ablation Combined with Immunotherapy for Lung Tumors].

Authors:  Baodong Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-04-20

7.  Impact of Elevated Circulating Histones on Systemic Inflammation after Radiofrequency Ablation in Lung Cancer Patients.

Authors:  Tao Gu; Tao Wen; Yunjie Zhang; Dan Zhang; Haixia Hua; Lijie Liu; Yanqiu Zhang; Zhanzhao Fu; Zhiyong Yuan
Journal:  Biomed Res Int       Date:  2017-12-31       Impact factor: 3.411

8.  Clinical Guideline for Microwave Ablation of Bone Tumors in Extremities.

Authors:  Kai Zheng; Xiuchun Yu; Yongcheng Hu; Yingze Zhang; Zhen Wang; Sujia Wu; Jingnan Shen; Zhaoming Ye; Chongqi Tu; Yu Zhang; Xing Wei; Yong Hu; Xuquan Wang; Jiazhen Li; Hong Duan; Yuxian Wu; Ming Xu; Zhenchao Yuan; Yongzhong Wei; Bingyao Chen
Journal:  Orthop Surg       Date:  2020-08-09       Impact factor: 2.071

9.  Changes in peripheral immune cells after intraoperative radiation therapy in low-risk breast cancer.

Authors:  Isabel Linares-Galiana; Miguel Angel Berenguer-Frances; Rut Cañas-Cortés; Monica Pujol-Canadell; Silvia Comas-Antón; Evelyn Martínez; Maria Laplana; Héctor Pérez-Montero; María Jesús Pla-Farnós; Arturo Navarro-Martin; Miriam Nuñez; Brigitte Both; Ferran Guedea
Journal:  J Radiat Res       Date:  2021-01-01       Impact factor: 2.724

10.  Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer.

Authors:  Wenbin Zhou; Muxin Yu; Hong Pan; Wen Qiu; Hui Wang; Mengjia Qian; Nan Che; Kai Zhang; Xinrui Mao; Li Li; Ruoxi Wang; Hui Xie; Lijun Ling; Yi Zhao; Xiaoan Liu; Cong Wang; Qiang Ding; Shui Wang
Journal:  J Immunother Cancer       Date:  2021-04       Impact factor: 13.751

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.